Anti-NGAL antibody
Specifications
| Product Cat#: | AB-06-3131 |
| Product type: | Primary antibody |
| Antigen: | NGAL |
| Immunogen: | Recombinant protein |
| Species immunized: | Mouse |
| Isotype: | IgG |
| Applications: | ELISA( 1:5,000-1:10,000); Western Blot (1:1000); Immunocytochemistry (1:50-1:200); Immunohistochemistry(1:50-1:200) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal(AH22-11) |
| Form: | Liquid |
| Buffer: | 1*TBS (pH7.4), 1% BSA, 40% Glycerol. Preservative: 0.11% Sodium Azide. |
| Concentration: | 1 mg/ml |
| Purity: | Antigen affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | 24p3 antibody |
| 25 kDa alpha 2 microglobulin related subunit of MMP9 antibody | |
| 25 kDa alpha-2-microglobulin-related subunit of MMP-9 antibody | |
| Alpha 2 microglobulin related protein antibody | |
| HGNC:6526 antibody | |
| HNL antibody | |
| Lcn 2 antibody | |
| Lcn2 antibody | |
| Lipocalin-2 antibody | |
| Migration stimulating factor inhibitor antibody | |
| MSFI antibody | |
| Neutrophil gelatinase associated lipocalin antibody | |
| Neutrophil gelatinase associated lipocalin precursor antibody | |
| Neutrophil gelatinase-associated lipocalin antibody | |
| NGAL antibody | |
| NGAL_HUMAN antibody | |
| Oncogene 24p3 antibody | |
| Oncogenic lipocalin 24p3 antibody |
Target information
In addition to the monomeric mammalian progelatinase, two additional forms of progelatinase have been identified. The shorter of these additional forms is a covalently linked, disulfide-bridged protein that heterodimerizes with a short protein; an α2-Microglobulin-related protein known as neutrophil gelatinase-associated lipocalin (NGAL), which is moderately expressed in breast and lung tissues. NGAL belongs to the lipocalin family and has a high degree of similarity with rat α2-Microglobulin-related protein and mouse protein 24p3. NGAL is able to bind a derivative of the bacterial chemotactic peptide, suggesting that it has important immuno-modulatory functions. NGAL has been described as an inflammatory protein; it is released into the circulation as a result of the inflammatory activation of leukocytes initiated by the extra-corporeal circulation. In addition, NGAL synthesis is induced in epithelial cells in inflammatory and neoplastic colorectal diseases. In conclusion, NGAL may serve as a scavenger of bacterial products to function in the anti-inflammatory process.
Provider
Erpantech Laboratory